General MedicationsINJECTIONGeneric
CALCIPARINE
HEPARIN CALCIUM
Standard Dose
25,000 UNITS/ML
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary
Approval overview CALCIPARINE is listed in Drugs@FDA under application 018237 (NDA).
Marketing status: Discontinued Active ingredient HEPARIN CALCIUM Form and strength INJECTABLE;INJECTION - 25,000 UNITS/ML Sponsor SANOFI AVENTIS US Submission history See approval history documents.
Structured Monograph
Clinical summary
Approval overview CALCIPARINE is listed in Drugs@FDA under application 018237 (NDA). Marketing status: Discontinued Active ingredient HEPARIN CALCIUM Form and strength INJECTABLE;INJECTION - 25,000 UNITS/ML Sponsor SANOFI AVENTIS US Submission history See approval history documents.
Monitoring
- • Marketing status: Discontinued
Interaction Notes
- No interaction notes stored yet.